Literature DB >> 29395264

Effect of symptoms on physical performance in COPD.

Jungeun Lee1, Huong Q Nguyen2, Monica E Jarrett3, Pamela H Mitchell3, Kenneth C Pike3, Vincent S Fan4.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) patients experience multiple symptoms including dyspnea, anxiety, depression, and fatigue, which are highly correlated with each other. Together, those symptoms may contribute to impaired physical performance.
OBJECTIVES: The purpose of this study was to examine interrelationships among dyspnea, anxiety, depressive symptoms, and fatigue as contributing factors to physical performance in COPD.
METHODS: This study used baseline data of 282 COPD patients from a longitudinal observational study to explore the relationship between depression, inflammation, and functional status. Data analyses included confirmatory factor analyses and structural equation modeling.
RESULTS: Dyspnea, anxiety and depression had direct effects on fatigue, and both dyspnea and anxiety had direct effects on physical performance. Higher levels of dyspnea were significantly associated with impaired physical performance whereas higher levels of anxiety were significantly associated with enhanced physical performance.
CONCLUSION: Dyspnea was the strongest predictor of impaired physical performance in patients with COPD. Published by Elsevier Inc.

Entities:  

Keywords:  COPD; Dyspnea; Fatigue; Physical performance; Psychological symptoms

Mesh:

Year:  2018        PMID: 29395264      PMCID: PMC5857230          DOI: 10.1016/j.hrtlng.2017.12.007

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  47 in total

1.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

2.  Functional and psychological variables both affect daily physical activity in COPD: a structural equations model.

Authors:  Wytske A Altenburg; Linda Bossenbroek; Mathieu H G de Greef; Huib A M Kerstjens; Nick H T ten Hacken; Johan B Wempe
Journal:  Respir Med       Date:  2013-06-28       Impact factor: 3.415

Review 3.  The middle-range theory of unpleasant symptoms: an update.

Authors:  E R Lenz; L C Pugh; R A Milligan; A Gift; F Suppe
Journal:  ANS Adv Nurs Sci       Date:  1997-03       Impact factor: 1.824

4.  Subgroup analysis of symptoms and their effect on functioning, exercise capacity, and physical activity in patients with severe chronic obstructive pulmonary disease.

Authors:  Soo Kyung Park; Catherine A Meldrum; Janet L Larson
Journal:  Heart Lung       Date:  2013-09-20       Impact factor: 2.210

5.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

6.  A measure of quality of life for clinical trials in chronic lung disease.

Authors:  G H Guyatt; L B Berman; M Townsend; S O Pugsley; L W Chambers
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

Review 7.  Sleep disorders in chronic obstructive pulmonary disease: etiology, impact, and management.

Authors:  Rohit Budhiraja; Tauseef A Siddiqi; Stuart F Quan
Journal:  J Clin Sleep Med       Date:  2015-03-15       Impact factor: 4.062

8.  Physical activity in patients with COPD.

Authors:  H Watz; B Waschki; T Meyer; H Magnussen
Journal:  Eur Respir J       Date:  2008-11-14       Impact factor: 16.671

9.  Impact of changes in physical activity on health-related quality of life among patients with COPD.

Authors:  C Esteban; J M Quintana; M Aburto; J Moraza; M Egurrola; J Pérez-Izquierdo; S Aizpiri; U Aguirre; A Capelastegui
Journal:  Eur Respir J       Date:  2010-01-14       Impact factor: 16.671

10.  Physical activity and clinical and functional status in COPD.

Authors:  Judith Garcia-Aymerich; Ignasi Serra; Federico P Gómez; Eva Farrero; Eva Balcells; Diego A Rodríguez; Jordi de Batlle; Elena Gimeno; David Donaire-Gonzalez; Mauricio Orozco-Levi; Jaume Sauleda; Joaquim Gea; Robert Rodriguez-Roisin; Josep Roca; Àlvar G Agustí; Josep M Antó
Journal:  Chest       Date:  2009-03-02       Impact factor: 9.410

View more
  2 in total

1.  Combination adjunctive nebulized furosemide and salbutamol versus single agent therapy in COPD patients: A randomized controlled trial.

Authors:  Mohammadali Saba; Abdoulhossein Davoodabadi; Azin Ghaffari; Hamidreza Gilasi; Babak Haghpanah
Journal:  Ann Med Surg (Lond)       Date:  2020-07-18

2.  Pulmonary Rehabilitation Reduces Subjective Fatigue in COPD: A Responder Analysis.

Authors:  Maarten Van Herck; Jeanine Antons; Jan H Vercoulen; Yvonne M J Goërtz; Zjala Ebadi; Chris Burtin; Daisy J A Janssen; Melissa S Y Thong; Jacqueline Otker; Arnold Coors; Mirjam A G Sprangers; Jean W M Muris; Judith B Prins; Martijn A Spruit; Jeannette B Peters
Journal:  J Clin Med       Date:  2019-08-20       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.